WhichRecall
Class IIReported 2025-12-17

Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-274-01

Recalled by Lupin Pharmaceuticals Inc.

Reason for Recall

Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.

Advertisement
Recall Number
D-0220-2026
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-11-13
Reported
2025-12-17
Distribution
FL, MA, MI & OH
Code Info
Lot #: WB00006, Exp 12/31/2026
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement